老年动脉粥样硬化性心血管病调脂抗炎治疗进展

Progress of anti inflammation and anti inflammation treatment of atherosclerotic cardiovascular disease in

动脉粥样硬化性心血管病(ASCVD)是导致老年人死亡的主要原因,大量的循证医学证据表明他汀类药物具有调脂及调脂外的抗炎、抗栓、改善内皮、稳定斑块等抗动脉粥样硬化作用。由于老年人生理特点的特殊性,研究安全、有效、耐受性好和依从性高的ASCVD调脂抗炎防治方案是我们急需解决的课题。本文综述了老年ASCVD近10余年来的调脂抗炎治疗进展情况。

Atherosclerotic cardiovascular disease（ASCVD）is the leading cause of death in the elderly,a lot of evidence that statins have lipid and lipid regulating the anti-inflammatory and anti atherosclerotic effects of anti thrombus,improving endothelial and plaque stability etc..Because of the special characteristics of the physiological characteristics of the elderly,it is an urgent task to study the anti-inflammatory and anti-inflammatory and anti-inflammatory and anti-inflammatory and antiinflammation of ASCVD,which is safe,effective,well tolerated and compliant.This review summarizes the progress in the treatment of anti inflammation and anti inflammation in elderly patients with ASCVD in recent 10 years.